Range Low Price High Price Comment
30 days $1.69 $3.88 Monday, 29th Apr 2024 ABIO stock ended at $3.43. This is 4.19% less than the trading day before Friday, 26th Apr 2024. During the day the stock fluctuated 5.26% from a day low at $3.42 to a day high of $3.60.
90 days $1.57 $3.88
52 weeks $1.56 $3.88

Historical ARCA biopharma prices

Date Open High Low Close Volume
Feb 01, 2016 $3.80 $3.80 $3.80 $3.80 21 200
Jan 29, 2016 $3.79 $3.79 $3.79 $3.79 17 100
Jan 28, 2016 $3.70 $3.70 $3.70 $3.70 34 500
Jan 27, 2016 $3.86 $3.86 $3.86 $3.86 23 600
Jan 26, 2016 $3.98 $3.98 $3.98 $3.98 9 100
Jan 25, 2016 $3.97 $3.97 $3.97 $3.97 12 300
Jan 22, 2016 $3.84 $3.84 $3.84 $3.84 10 700
Jan 21, 2016 $3.97 $3.97 $3.97 $3.97 9 600
Jan 20, 2016 $3.83 $3.83 $3.83 $3.83 25 700
Jan 19, 2016 $3.85 $3.85 $3.85 $3.85 31 300
Jan 15, 2016 $3.56 $3.56 $3.56 $3.56 24 200
Jan 14, 2016 $3.61 $3.61 $3.61 $3.61 43 800
Jan 13, 2016 $3.49 $3.49 $3.49 $3.49 55 800
Jan 12, 2016 $3.78 $3.78 $3.78 $3.78 85 000
Jan 11, 2016 $4.35 $4.35 $4.35 $4.35 119 900
Jan 08, 2016 $4.45 $4.45 $4.45 $4.45 44 200
Jan 07, 2016 $4.42 $4.42 $4.42 $4.42 68 600
Jan 06, 2016 $4.60 $4.60 $4.60 $4.60 23 900
Jan 05, 2016 $4.78 $4.78 $4.78 $4.78 16 300
Click to get the best stock tips daily for free!

About ARCA biopharma

ARCA biopharma ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase... ABIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT